Table 2.
Positiona,b | Baseline count (n = 234) |
Baseline PI resistance mutations in virologic nonresponders at week 16 (n = 149)c,d |
Baseline PI resistance mutations in virologic responders at week 16 (n = 67)c,e |
Week 16 PI resistance mutations in virologic nonresponders (n = 141)c,d |
---|---|---|---|---|
10L (wt) | 127 | 71 | 46 | 60 |
10F/I/R/V/Z | 14, 87, 6, 9, 2 | 10, 62, 4, 8, 1 | 3, 18, 1, 0, 0 | 10, 72, 1, 6, 0 |
24L (wt) | 210 | 130 | 65 | 118 |
24I/F/Z | 24, 0, 0 | 19, 0, 0 | 2, 0, 0 | 22, 1, 1 |
36M (wt) | 194 | 122 | 56 | 105 |
36I/L | 38, 3 | 25, 2 | 10, 1 | 34, 2 |
46M (wt) | 117 | 67 | 39 | 74 |
46I/L/V | 84, 49, 0 | 62, 28, 0 | 19, 15, 0 | 49, 25, 1 |
47I (wt) | 221 | 145 | 60 | 140 |
47V | 13 | 4 | 7 | 1 |
48G (wt) | 234 | 149 | 67 | 128 |
48V/Z | 0, 0 | 0, 0 | 0, 0 | 11, 2 |
53F (wt) | 229 | 146 | 67 | 118 |
53L/Y/Z | 4, 0, 1 | 2, 0, 1 | 2, 0, 0 | 21, 1, 1 |
54I (wt) | 190 | 118 | 57 | 92 |
54T/V/A/L | 1, 43, 2, 0 | 0, 30, 1, 0 | 1, 10, 1, 0 | 0, 47, 0, 2 |
63L (wt) | 28 | 15 | 11 | 13 |
63P/Z | 181, 33 | 122, 16 | 46, 12 | 117, 16 |
71A (wt) | 139 | 83 | 47 | 66 |
71T/V/I | 32, 64, 5 | 21, 46, 4 | 8, 12, 1 | 16, 59, 6 |
73G (wt) | 202 | 122 | 65 | 103 |
73C/S/T/Z | 4, 23, 5, 1 | 4, 19, 4, 1 | 0, 1, 1, 0 | 5, 30, 9, 4 |
82V (wt) | 117 | 77 | 33 | 82 |
82A/F/I/S/T | 96, 11, 3, 2, 17 | 61, 4, 1, 2, 11 | 26, 6, 0, 0, 5 | 49, 2, 2, 1, 7 |
84I (wt) | 222 | 139 | 65 | 101 |
84V/A/Z | 12, 0, 0 | 10, 0, 0 | 2, 0, 0 | 40, 3, 2 |
88N (wt) | 219 | 135 | 66 | 128 |
88D/S/T/Z | 9, 5, 1, 1 | 8, 5, 1, 1 | 1, 0, 0, 0 | 7, 5, 1 |
90L (wt) | 191 | 115 | 59 | 77 |
90M | 43 | 34 | 8 | 65 |
93I (wt) | 114 | 72 | 33 | 80 |
93L/Z | 120, 1 | 77, 0 | 34, 1 | 61, 0 |
Z represents any other polymorphism different from wild-type.
Positions with low frequencies of substitutions that were not significantly different or associated with a virologic response include codons 20, 30, 32, 33, and 50.
Numbers in bold font (p value <0.05).
Virologic nonresponders = subjects with HIV-1 viral RNA load >500 copies/ml.
Virologic responders = subjects with HIV-1 viral RNA load ≥500 copies/ml.